Market Announcement 29 October 2026 Neurizon Therapeutics Limited (ASX: NUZ) – Trading Halt Trading in the securities of Neurizon Therapeutics Limited (‘NUZ’) will be halted at the request of NUZ, pending the release of an announcement by NUZ. Unless ASX decides otherwise, the securities will...
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1836
6ix is reading this filing.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Appendix 4C & Quarterly Update
- FDA Type C Feedback, HEALEY trial potentially registrational
- Neurizon Announces Partial Redemption of Convertible Notes
- NIH funds Expanded Access Program for NUZ-001 in ALS
- Neurizon Appoints Chief Executive Officer
Later from Neurizon Therapeutics
- Firm commitments to raise A$4.3m and announcement of SPP
- Redemption of all remaining Obsidian convertible notes
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics